FDA Says No to Serelaxin for Heart Failure MedPage Today "We continue to believe RLX030 has the potential to be an important treatment for acute heart failure and have been encouraged by feedback from FDA advisory committee members noting the data are intriguing," Tim Wright, global head of development for ... |
